MannKind
Why Robinhood?
Robinhood gives you the tools you need to put your money in motion. You can buy or sell MannKind and other ETFs, options, and stocks.About MNKD
MannKind Corp. is a biopharmaceutical company, which focuses on the development and commercialization of innovative therapeutic products and devices to address serious unmet medical needs for those living with endocrine and orphan lung diseases. Its products and pipeline include Afrezza, Pediatric Afrezza, V-Go, Tyvaso DPI, MNKD-101, MNKD-201, MNKD-301, and MNKD-501.
MNKD Key Statistics
MNKD News
On August 24, 2025, United Therapeutics announced an amendment to its collaboration agreement with MannKind, broadening the partnership to cover an additional d...
MannKind Corporation ( ) shareholders would be excited to see that the share price has had a great month, posting a 53% gain and recovering from prior weakness....
H.C. Wainwright analyst Brandon Folkes reiterated a Buy rating on MannKind today and set a price target of $11.00. Elevate Your Investing Strategy: Take advanta...
Analyst ratings
100%
of 8 ratingsMore MNKD News
H.C. Wainwright raised the firm’s price target on MannKind (MNKD) to $11 from $9 and keeps a Buy rating on the shares. United Therapeutics (UTHR) announced that...
Analyst Yun Zhong of Wedbush maintained a Buy rating on MannKind, retaining the price target of $11.00. Elevate Your Investing Strategy: Take advantage of TipRa...